On August 11, Oklo Inc. rose 5.01% in regular trading, trading at $46.785/share, with turnover of $163 million. The stock rebounded following a 5.69% decline in the prior session triggered by wider-than-expected Q2 losses and executive share sale plans.
On the news front, the U.S. Department of Energy announced that Oklo's small modular nuclear reactor achieved criticality status, a key milestone in the company's advanced nuclear energy commercialization path. The company's Q2 results also showed first-ever quarterly revenue of $1.21 million, far exceeding the analyst consensus estimate of approximately $126,000, though per-share losses of $0.28 missed estimates of $0.16 by 75%. The company holds approximately $3 billion in cash and marketable securities as of quarter-end, providing substantial runway for its capital-intensive reactor development program.
Several analysts subsequently cut their forecasts on Oklo, with shares having declined 7.7% from recent highs. CEO Jacob DeWitte and COO Caroline Cochran each filed Form 144 to sell 400,000 shares of Class A common stock, totaling approximately $31 million in market value, which continues to weigh on near-term sentiment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments